(Q38120063)

29 August 2017

title

Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review (English)

1 reference

29 August 2017

1 reference

hepatocellular carcinoma

1 reference

Changzai Li

1 reference

29 August 2017

Zhiming Zhang

series ordinal

1 reference

29 August 2017

Pan Zhang

series ordinal

1 reference

29 August 2017

Jianyong Liu

series ordinal

1 reference

29 August 2017

publication date

19 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

page(s)

E11-25

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

A comparison between des-gamma-carboxy prothrombin and alpha-fetoprotein as markers of hepatocellular carcinoma in southern African blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

A novel biomarker TERTmRNA is applicable for early detection of hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

EASL Clinical Practice Guidelines: Wilson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Hepatocellualar carcinoma serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

New serum markers of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Newer markers for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

NX-PVKA assay, a conventional but refined prognostic biomarker for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Diagnostic performance of des-γ-carboxy prothrombin (DCP) for hepatocellular carcinoma: a bivariate meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Development of a Novel Assay to Quantify Serum Human Telomerase Reverse Transcriptase Messenger RNA and Its Significance as a Tumor Marker for Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Biomarkers for early diagnosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

Des-Gamma-Carboxyprothrombin for Early Identification and Prognosis of Hepatocellular Carcinoma - A Case Control Study from Western Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12201

21 January 2018

Identifiers

DOI

10.1111/HEPR.12201

1 reference

29 August 2017

1 reference